Dsm-firmenich’s Carl D’Ruiz explains during an Oct. 14 webinar how BEMT is enabling US formulators to make more creative and ...
CMS is eager to work with Congress to control premium growth in Part D once the existing 6% cap on the base beneficiary ...
Brent Saunders apparently wasn’t a cog in B+L’s confidence in expecting to increase its full-year guidance. Canadian firm ...
Barry Chaiken says AI chatbots are eroding guided self-care and that the industry, rather than tech companies, should set ...
Phase I/IIa data for the siRNA drug showed it can cross the blood-brain barrier when administered via subcutaneous injection, ...
Third quarter data from Evaluate show nine biopharma initial public offerings on Western exchanges totaling $2.39bn. Average ...
The FDA’s cross-agency initiative to build a fit-for-purpose framework would expand reviewer engagement with external experts ...
Iilun Murphy decided to step down as Office of Generic Drugs director for an associate director position, another senior ...
The MedTech Conference, hosted by AdvaMed, will bring more than 4,000 industry leaders to Boston Oct. 18–21 to discuss major ...
With the revised EU pharma directive making antimicrobials prescription-only by default, AESGP and national associations in ...
An Oklahoma chiropractor is set to serve 14 years in prison for his role at the center of a durable medical equipment fraud ...
There are many treatments for inherited retinal dystrophies in development, including products from SparingVision, Atsena and Ocugen. Guidance is needed to address the distinct challenges involved ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results